ID   M10L1_HUMAN             Reviewed;        1211 AA.
AC   Q9BXT6; A7E211; A8MXC6; B7WPP1; B7Z7R1; F5H403; Q5TGD5; Q8NBD4; Q9NXW3;
AC   Q9UFB3; Q9UGX9;
DT   02-AUG-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   28-JUN-2023, entry version 169.
DE   RecName: Full=RNA helicase Mov10l1 {ECO:0000305};
DE            EC=3.6.4.13 {ECO:0000250|UniProtKB:Q99MV5};
DE   AltName: Full=Moloney leukemia virus 10-like protein 1 {ECO:0000312|HGNC:HGNC:7201};
DE            Short=MOV10-like protein 1 {ECO:0000312|HGNC:HGNC:7201};
GN   Name=MOV10L1 {ECO:0000312|HGNC:HGNC:7201};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=11279525; DOI=10.1038/86927;
RA   Wang P.J., McCarrey J.R., Yang F., Page D.C.;
RT   "An abundance of X-linked genes expressed in spermatogonia.";
RL   Nat. Genet. 27:422-426(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3 AND 5), AND VARIANT
RP   ARG-820.
RC   TISSUE=Adipose tissue, Cerebellum, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND VARIANT LEU-454.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 534-1211, AND VARIANTS LEU-454;
RP   ARG-820 AND GLU-1179.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   VARIANTS SPGF73 ILE-816 AND ARG-848, AND INVOLVEMENT IN SPGF73.
RX   PubMed=35476666; DOI=10.1056/nejmc2116008;
RA   Li L., Tan Y.Q., Lu L.Y.;
RT   "Defective piRNA Processing and Azoospermia.";
RL   N. Engl. J. Med. 386:1675-1676(2022).
CC   -!- FUNCTION: ATP-dependent RNA helicase required during spermatogenesis to
CC       repress transposable elements and prevent their mobilization, which is
CC       essential for germline integrity. Acts via the piRNA metabolic process,
CC       which mediates the repression of transposable elements during meiosis
CC       by forming complexes composed of piRNAs and Piwi proteins and governs
CC       the methylation and subsequent repression of transposons. Involved in
CC       the primary piRNA metabolic process. Specifically binds to piRNA
CC       precursors and promotes the generation of intermediate piRNA processing
CC       fragments that are subsequently loaded to Piwi proteins. Acts via its
CC       ATP-dependent RNA helicase activity: displays 5'-3' RNA unwinding
CC       activity and probably mediates unwinding and funneling of single-
CC       stranded piRNA precursor transcripts to the endonuclease that catalyzes
CC       the first cleavage step of piRNA processing to generate piRNA
CC       intermediate fragments that are subsequently loaded to Piwi proteins.
CC       {ECO:0000250|UniProtKB:Q99MV5}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.13;
CC         Evidence={ECO:0000250|UniProtKB:Q99MV5};
CC   -!- SUBUNIT: Interacts with PIWIL1. Interacts with PIWIL2. Interacts with
CC       PIWIL4. Interacts with HSPA2. Interacts with PLD6.
CC       {ECO:0000250|UniProtKB:Q99MV5}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q99MV5}.
CC       Note=Component of the meiotic nuage, also named P granule, a germ-cell-
CC       specific organelle required to repress transposon activity during
CC       meiosis. {ECO:0000250|UniProtKB:Q99MV5}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q9BXT6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BXT6-2; Sequence=VSP_003390, VSP_003391;
CC       Name=3;
CC         IsoId=Q9BXT6-3; Sequence=VSP_010945, VSP_010946, VSP_010947,
CC                                  VSP_010948;
CC       Name=4;
CC         IsoId=Q9BXT6-4; Sequence=VSP_045413;
CC       Name=5;
CC         IsoId=Q9BXT6-5; Sequence=VSP_046082, VSP_046083;
CC   -!- TISSUE SPECIFICITY: [Isoform 1]: Specifically expressed in testis.
CC       {ECO:0000269|PubMed:11279525}.
CC   -!- DISEASE: Spermatogenic failure 73 (SPGF73) [MIM:619878]: An autosomal
CC       recessive male infertility disorder characterized by non-obstructive
CC       azoospermia due to meiotic arrest. {ECO:0000269|PubMed:35476666}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- SIMILARITY: Belongs to the DNA2/NAM7 helicase family. SDE3 subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF285604; AAK31983.1; -; mRNA.
DR   EMBL; AK000033; BAA90895.1; -; mRNA.
DR   EMBL; AK090740; BAC03511.1; -; mRNA.
DR   EMBL; AK302401; BAH13697.1; -; mRNA.
DR   EMBL; CR456466; CAG30352.1; -; mRNA.
DR   EMBL; AL022328; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL034546; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC150137; AAI50138.1; -; mRNA.
DR   EMBL; BC152539; AAI52540.1; -; mRNA.
DR   EMBL; AL133068; CAB61391.1; -; mRNA.
DR   CCDS; CCDS14084.1; -. [Q9BXT6-1]
DR   CCDS; CCDS54541.1; -. [Q9BXT6-4]
DR   CCDS; CCDS54542.1; -. [Q9BXT6-5]
DR   CCDS; CCDS54543.1; -. [Q9BXT6-2]
DR   PIR; T42668; T42668.
DR   RefSeq; NP_001157576.1; NM_001164104.1. [Q9BXT6-4]
DR   RefSeq; NP_001157577.1; NM_001164105.1. [Q9BXT6-5]
DR   RefSeq; NP_001157578.1; NM_001164106.1. [Q9BXT6-2]
DR   RefSeq; NP_061868.1; NM_018995.2. [Q9BXT6-1]
DR   AlphaFoldDB; Q9BXT6; -.
DR   BioGRID; 119963; 5.
DR   IntAct; Q9BXT6; 1.
DR   STRING; 9606.ENSP00000262794; -.
DR   GlyCosmos; Q9BXT6; 1 site, 2 glycans.
DR   GlyGen; Q9BXT6; 1 site, 2 O-linked glycans (1 site).
DR   iPTMnet; Q9BXT6; -.
DR   PhosphoSitePlus; Q9BXT6; -.
DR   BioMuta; MOV10L1; -.
DR   DMDM; 22095856; -.
DR   EPD; Q9BXT6; -.
DR   jPOST; Q9BXT6; -.
DR   MassIVE; Q9BXT6; -.
DR   PaxDb; Q9BXT6; -.
DR   PeptideAtlas; Q9BXT6; -.
DR   ProteomicsDB; 2313; -.
DR   ProteomicsDB; 26428; -.
DR   ProteomicsDB; 79508; -. [Q9BXT6-1]
DR   ProteomicsDB; 79509; -. [Q9BXT6-2]
DR   ProteomicsDB; 79510; -. [Q9BXT6-3]
DR   Antibodypedia; 14100; 112 antibodies from 20 providers.
DR   DNASU; 54456; -.
DR   Ensembl; ENST00000262794.10; ENSP00000262794.5; ENSG00000073146.16. [Q9BXT6-1]
DR   Ensembl; ENST00000354853.2; ENSP00000346917.2; ENSG00000073146.16. [Q9BXT6-3]
DR   Ensembl; ENST00000395852.5; ENSP00000379193.1; ENSG00000073146.16. [Q9BXT6-2]
DR   Ensembl; ENST00000395858.7; ENSP00000379199.3; ENSG00000073146.16. [Q9BXT6-4]
DR   Ensembl; ENST00000540615.5; ENSP00000438542.1; ENSG00000073146.16. [Q9BXT6-5]
DR   Ensembl; ENST00000545383.5; ENSP00000438978.1; ENSG00000073146.16. [Q9BXT6-1]
DR   GeneID; 54456; -.
DR   KEGG; hsa:54456; -.
DR   MANE-Select; ENST00000262794.10; ENSP00000262794.5; NM_018995.3; NP_061868.1.
DR   UCSC; uc003bjj.4; human. [Q9BXT6-1]
DR   AGR; HGNC:7201; -.
DR   CTD; 54456; -.
DR   DisGeNET; 54456; -.
DR   GeneCards; MOV10L1; -.
DR   HGNC; HGNC:7201; MOV10L1.
DR   HPA; ENSG00000073146; Tissue enriched (testis).
DR   MalaCards; MOV10L1; -.
DR   MIM; 605794; gene.
DR   MIM; 619878; phenotype.
DR   neXtProt; NX_Q9BXT6; -.
DR   OpenTargets; ENSG00000073146; -.
DR   PharmGKB; PA30909; -.
DR   VEuPathDB; HostDB:ENSG00000073146; -.
DR   eggNOG; KOG1804; Eukaryota.
DR   GeneTree; ENSGT00940000160150; -.
DR   HOGENOM; CLU_001666_3_1_1; -.
DR   InParanoid; Q9BXT6; -.
DR   OMA; YCATVDI; -.
DR   OrthoDB; 170190at2759; -.
DR   PhylomeDB; Q9BXT6; -.
DR   TreeFam; TF323999; -.
DR   PathwayCommons; Q9BXT6; -.
DR   Reactome; R-HSA-5601884; PIWI-interacting RNA (piRNA) biogenesis.
DR   SignaLink; Q9BXT6; -.
DR   BioGRID-ORCS; 54456; 10 hits in 1145 CRISPR screens.
DR   ChiTaRS; MOV10L1; human.
DR   GenomeRNAi; 54456; -.
DR   Pharos; Q9BXT6; Tbio.
DR   PRO; PR:Q9BXT6; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; Q9BXT6; protein.
DR   Bgee; ENSG00000073146; Expressed in right testis and 94 other tissues.
DR   ExpressionAtlas; Q9BXT6; baseline and differential.
DR   Genevisible; Q9BXT6; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0043186; C:P granule; ISS:UniProtKB.
DR   GO; GO:0071546; C:pi-body; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; TAS:UniProtKB.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:RHEA.
DR   GO; GO:0000287; F:magnesium ion binding; TAS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IBA:GO_Central.
DR   GO; GO:0003724; F:RNA helicase activity; ISS:UniProtKB.
DR   GO; GO:0043046; P:DNA methylation involved in gamete generation; ISS:UniProtKB.
DR   GO; GO:0007281; P:germ cell development; IEP:UniProtKB.
DR   GO; GO:0007141; P:male meiosis I; ISS:UniProtKB.
DR   GO; GO:0035194; P:ncRNA-mediated post-transcriptional gene silencing; IBA:GO_Central.
DR   GO; GO:0034587; P:piRNA processing; ISS:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; IEP:UniProtKB.
DR   CDD; cd18078; DEXXQc_Mov10L1; 1.
DR   CDD; cd18808; SF1_C_Upf1; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2.
DR   InterPro; IPR041679; DNA2/NAM7-like_C.
DR   InterPro; IPR041677; DNA2/NAM7_AAA_11.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR047187; SF1_C_Upf1.
DR   PANTHER; PTHR45418; CANCER/TESTIS ANTIGEN 55; 1.
DR   PANTHER; PTHR45418:SF1; CANCER/TESTIS ANTIGEN 55; 1.
DR   Pfam; PF13086; AAA_11; 2.
DR   Pfam; PF13087; AAA_12; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cytoplasm; Developmental protein;
KW   Disease variant; Helicase; Hydrolase; Nucleotide-binding;
KW   Reference proteome.
FT   CHAIN           1..1211
FT                   /note="RNA helicase Mov10l1"
FT                   /id="PRO_0000080706"
FT   REGION          340..385
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          674..710
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1192..1211
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           886..889
FT                   /note="DEAG box"
FT   COMPBIAS        340..373
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        674..692
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        693..710
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         770..777
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..902
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_010945"
FT   VAR_SEQ         1..873
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_003390"
FT   VAR_SEQ         1..32
FT                   /note="MLSLAAKLVAFFWRTADTPREEAGQLEPELAE -> MSFLPVRSVIGG (in
FT                   isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046082"
FT   VAR_SEQ         874..875
FT                   /note="GV -> MF (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_003391"
FT   VAR_SEQ         910..964
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_010946"
FT   VAR_SEQ         1074..1082
FT                   /note="EKIRILLRN -> RPAQARLVL (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_010947"
FT   VAR_SEQ         1083..1211
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_010948"
FT   VAR_SEQ         1109..1154
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_045413"
FT   VAR_SEQ         1155..1211
FT                   /note="DPCFGALLEYSITNGVYMGCDLPPALQSLQNCGEGVADPSYPVVPESTGPEK
FT                   HQEPS -> LWRGGGRPLLPSGARIHRTREASGAQLICSG (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046083"
FT   VARIANT         18
FT                   /note="T -> S (in dbSNP:rs12628964)"
FT                   /id="VAR_059457"
FT   VARIANT         57
FT                   /note="M -> L (in dbSNP:rs9617066)"
FT                   /id="VAR_034100"
FT   VARIANT         182
FT                   /note="R -> C (in dbSNP:rs3810971)"
FT                   /id="VAR_020148"
FT   VARIANT         454
FT                   /note="I -> L (in dbSNP:rs760749)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:17974005"
FT                   /id="VAR_013694"
FT   VARIANT         650
FT                   /note="V -> I (in dbSNP:rs2340601)"
FT                   /id="VAR_013695"
FT   VARIANT         683
FT                   /note="S -> G (in dbSNP:rs3736689)"
FT                   /id="VAR_034101"
FT   VARIANT         816
FT                   /note="S -> I (in SPGF73)"
FT                   /evidence="ECO:0000269|PubMed:35476666"
FT                   /id="VAR_087327"
FT   VARIANT         820
FT                   /note="Q -> R (in dbSNP:rs2272837)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:17974005"
FT                   /id="VAR_013696"
FT   VARIANT         848
FT                   /note="G -> R (in SPGF73; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:35476666"
FT                   /id="VAR_087328"
FT   VARIANT         1179
FT                   /note="A -> E (in dbSNP:rs2272843)"
FT                   /evidence="ECO:0000269|PubMed:17974005"
FT                   /id="VAR_013697"
FT   CONFLICT        321
FT                   /note="Q -> H (in Ref. 2; BAH13697)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1016
FT                   /note="L -> P (in Ref. 2; BAH13697)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1063
FT                   /note="I -> V (in Ref. 2; BAA90895)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1096
FT                   /note="F -> L (in Ref. 2; BAA90895)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1211 AA;  135293 MW;  410716BDCC85F8B1 CRC64;
     MLSLAAKLVA FFWRTADTPR EEAGQLEPEL AEGDTKLKTV RGVVTRYCSD YGMIDDMIYF
     SSDAVTSRVL LNVGQEVIAV VEENKVSNGL KAIRVEAVSD KWEDDSRNHG SPSDCGPRVL
     IGCVTSLVEG AGCISQTTYF SLESVCEGFE PCKGDWVEAE YRIRPGTWSS EATSVKPLRY
     KRVDKVCISS LCGRNGVLEE SIFFTLDSLK LPDGYTPRRG DVVNAVVVES SQSCYVWRAL
     CMTLVKRRDA APVHEATHFY GTILLKNKGD IEVTQVTHFG TLKEGRSKTM VIWIENKGDI
     PQNLVSCKLA GWDKSKQFRF QMLDKDQMCP VVSFVSVPEK ENSSDENINS LNSHTKNKTS
     QMSESSLVNN RGISPGDCTC KGENGEKDNI LSRKQMTEPE PGGLVPPGGK TFIVVICDGK
     NPGRCKELLL LCFSDFLIGR YLEVNVISGE ESLIAAREPF SWKKLKSSQA LTSAKTTVVV
     TAQKRNSRRQ LPSFLPQYPI PDRLRKCVEQ KIDILTFQPL LAELLNMSNY KEKFSTLLWL
     EEIYAEMELK EYNMSGIILR RNGDLLVLEV PGLAEGRPSL YAGDKLILKT QEYNGHAIEY
     ISYVTEIHEE DVTLKINPEF EQAYNFEPMD VEFTYNRTTS RRCHFALEHV IHLGVKVLFP
     EEIILQSPQV TGNWNHAQDT KSSGQSTSKK NRKTMTDQAE HGTEERRVGD KDLPVLAPFT
     AEMSDWVDEI QTPKARKMEF FNPVLNENQK LAVKRILSGD CRPLPYILFG PPGTGKTVTI
     IEAVLQVHFA LPDSRILVCA PSNSAADLVC LRLHESKVLQ PATMVRVNAT CRFEEIVIDA
     VKPYCRDGED IWKASRFRII ITTCSSSGLF YQIGVRVGHF THVFVDEAGQ ASEPECLIPL
     GLMSDISGQI VLAGDPMQLG PVIKSRLAMA YGLNVSFLER LMSRPAYQRD ENAFGACGAH
     NPLLVTKLVK NYRSHEALLM LPSRLFYHRE LEVCADPTVV TSLLGWEKLP KKGFPLIFHG
     VRGSEAREGK SPSWFNPAEA VQVLRYCCLL AHSISSQVSA SDIGVITPYR KQVEKIRILL
     RNVDLMDIKV GSVEEFQGQE YLVIIISTVR SNEDRFEDDR YFLGFLSNSK RFNVAITRPK
     ALLIVLGNPH VLVRDPCFGA LLEYSITNGV YMGCDLPPAL QSLQNCGEGV ADPSYPVVPE
     STGPEKHQEP S
//
